Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Purpose This cookie is required by the CMS (Content Management System) TYPO3 for the system to function correctly.
Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the .anonymized measurement. mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Core Facility Antibodies

The CF Antibodies offers the production of monoclonal (mouse/rat) antibodies using the hybridoma technology and the production of polyclonal (guinea pig) ABs, that specifically recognize antigens giving low antibody responses in mice or rats. Since more than two decades we have successfully generated antibodies against proteins including splice variants, mutated and modified forms.

Our service includes the production of MABs for research projects and as diagnostic tools in histopathology. In addition, we offer non-GMP production and purification of mABs.

Lastly, we offer antibody sequencing, engineering and recombinant expression. These recombinant antibodies open new avenues of approaches in biomedical research, diagnostics and as therapeutics.

Many in-house produced antibodies are accessible for internal research purposes (antibody list).




+++ News +++

Our list of in-house distributable antibodies has been updated

More than 2000 monoclonal antibodies have been produced at the DKFZ in over 400 projects.
About 430 hybridoma of 260 projects are available for internal research purposes (11-2023).
For information on these antibodies and to address your requests please check out our antibody list.




























last update:
to top